We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
+9.62%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
AUM
$301M
AUM Growth
+$22.1M
Cap. Flow
-$1.58M
Cap. Flow %
-0.53%
Top 10 Hldgs %
30.26%
Holding
75
New
Increased
25
Reduced
38
Closed

Sector Composition

Rank Sector Weight
1 Technology 19.04%
2 Consumer Discretionary 18.3%
3 Healthcare 16.12%
4 Industrials 13.85%
5 Consumer Staples 11.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLGN icon
26
Silgan Holdings
SLGN
$4.99B
$5.52M 1.83%
205,908
-5,166
-2% -$130K
EV
27
DELISTED
Eaton Vance Corp.
EV
$5.4M 1.79%
132,000
+3,302
+3% +$130K
OA
28
DELISTED
Orbital ATK, Inc.
OA
$5.19M 1.72%
44,638
-2,796
-6% -$325K
KDP icon
29
Keurig Dr Pepper
KDP
$42.1B
$4.87M 1.62%
67,908
+7,362
+12% +$510K
DLTR icon
30
Dollar Tree
DLTR
$24.2B
$4.64M 1.54%
65,990
+1,950
+3% +$123K
ABBV icon
31
AbbVie
ABBV
$450B
$4.54M 1.51%
69,380
-125
-0.2% -$7.88K
CPRT icon
32
Copart
CPRT
$25.6B
$4.5M 1.5%
987,024
+23,648
+2% +$101K
K
33
DELISTED
Kellanova
K
$4.23M 1.41%
68,853
+228
+0.3% +$13.7K
DLX icon
34
Deluxe
DLX
$1.19B
$3.91M 1.3%
62,809
+953
+2% +$56K
NVO
35
Novo Nordisk
NVO
$223B
$3.8M 1.26%
179,550
+500
+0.3% +$11.2K
COL
36
DELISTED
Rockwell Collins
COL
$3.6M 1.19%
42,574
-745
-2% -$61.1K
CNI icon
37
Canadian National Railway
CNI
$78.3B
$3.54M 1.18%
51,407
+2,376
+5% +$163K
PDCO
38
DELISTED
Patterson Companies, Inc.
PDCO
$3.27M 1.09%
68,094
-475
-0.7% -$21.4K
DHR icon
39
Danaher
DHR
$144B
$3.01M 1%
52,250
-550
-1% -$29.8K
KMB icon
40
Kimberly-Clark
KMB
$36B
$2.66M 0.88%
23,050
-1,174
-5% -$130K
PKG icon
41
Packaging Corp of America
PKG
$20.8B
$2.55M 0.85%
32,695
+24,844
+316% +$1.78M
GPN icon
42
Global Payments
GPN
$21.3B
$2.53M 0.84%
62,716
+6,362
+11% +$255K
XOM icon
43
ExxonMobil
XOM
$611B
$2.43M 0.81%
26,331
-340
-1% -$31.7K
LH icon
44
Labcorp
LH
$23.2B
$2.29M 0.76%
24,756
-1,164
-4% -$103K
CLB icon
45
Core Laboratories
CLB
$523M
$2.21M 0.74%
18,394
-4,291
-19% -$564K
LLY icon
46
Eli Lilly
LLY
$1.05T
$2.2M 0.73%
31,954
-55
-0.2% -$3.71K
IBM icon
47
IBM
IBM
$200B
$2.19M 0.73%
14,272
-10
-0.1% -$1.59K
EXPD icon
48
Expeditors International
EXPD
$23.9B
$2.1M 0.7%
47,123
-5,195
-10% -$223K
MDT icon
49
Medtronic
MDT
$106B
$1.84M 0.61%
25,490
+225
+0.9% +$15.6K
TECH icon
50
Bio-Techne
TECH
$11.2B
$1.81M 0.6%
78,320

Similar funds

JLB & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, JLB & Associates held 75 positions worth $301M, up 7.9% from $279M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2014: portfolio turnover was 0%. JLB & Associates opened no new positions and made no exits, leaving the 75-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • JLB & Associates added most to Packaging Corp of America in Q4 2014, an estimated $1.78M increase.
  • JLB & Associates's biggest Q4 2014 reduction was Altera Corp, cutting an estimated $1.72M.
  • JLB & Associates's ten largest holdings make up 30% of its $301M portfolio in Q4 2014.
  • JLB & Associates opened 0 new positions and closed 0 in Q4 2014.
  • JLB & Associates's portfolio value rose 7.9% quarter-over-quarter to $301M.

Based on JLB & Associates's 13F filing for Q4 2014, filed 28 Jan 2015.